Anti-diabetic Drug Improves Heart and Kidney Health in Older Adults

Canagliflozin, a diabetes medication, improves heart and kidney health by reducing cardiovascular risks.

Diabetes drug canagliflozin benefits patients of all ages. While Sodium-glucose cotransporter-2 (SGLT2) inhibitors are known to reduce the risk of heart and kidney problems in people with type 2 diabetes, this study confirms their effectiveness regardless of age. The findings will be presented at ASN Kidney Week 2024. ()

The analysis pooled individual participant data from the CANVAS Program and CREDENCE trial and assessed efficacy and safety according to baseline age. Among the 14,543 participants, 7,927 (54.5%) were <65 years, 5,281 (36.3%) were 65 to <75 years, and 1,335 (9.2%) were ≥75 years.

Congestive Heart Failure
Congestive heart failure (CHF) is a condition in which the heart fails to work adequately as a pump that can deliver oxygen rich blood to the body.

‘#Anti-diabetic drug Canagliflozin shines bright! Across age groups, this SGLT2 inhibitor reduces risks of major #heart problems, #kidneydisease progression, and #heartfailure hospitalizations. #drug #diabetes ’

Although the overall incidence of adverse events increased with age, the effects of canagliflozin on safety outcomes including acute kidney injury, volume depletion, urinary tract infections and hypoglycemia, were not modified by age.

“The prevalence of diabetes among older adults aged ≥65 years in the United States is estimated at 29.2%, a prevalence rate more than double that for the overall adult population aged ≥18 years, and older individuals with diabetes have higher absolute risks of cardiovascular events and kidney complications."

"Despite this, real-world uptake of SGLT2 inhibitors in older age groups is among the lowest of all patient groups,” said corresponding author Amanda Siriwardana, MBBS (Hon), GCert Public Health, FRACP, of The George Institute for Global Health in Australia.

Quiz on Diabetes and Oral Health
Did you know that your dentist can identify signs of diabetes by just taking a peek in your mouth? Everyone should maintain good oral health, but those with high blood sugar are more susceptible to developing oral health issues. Maintaining ...

“The data presented in this analysis suggests clear extension of the cardiorenal benefits of SGLT2 therapy to older individuals and should engender confidence amongst clinicians and patients regarding the safety of canagliflozin in older adults.”

Reference:

Heart and Kidney Outcomes After Canagliflozin Treatment in Older Adults - (https://www.asn-online.org/about/press/releases/ASN_PR_20241025_Siriwardana10.17FIN.pdf)

Source-Eurekalert

Slide Multimedia Animation on Surgical Removal of Kidney or Nephrectomy - Animation
Graphical explanation of removal of kidney. This is sometimes necessary for a kidney that stops functioning or if it has a cancer in it. It is a major operation and requires hospitalization for 5 to 7 days.

Canagliflozin
This medication is an antidiabetic (sodium glucose co-transporter 2 (SGLT2) inhibitor), prescribed for type 2 diabetes mellitus along with diet and exercise. For patients with type 2 diabetes along with diabetic kidney disease, physicians should ...